Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0042961 (volvulus)
 4,305 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Detection of O. volvulus antigen by indirect ELISA test in the serum and the urine of 169 individuals with residence in the southeast onchocerciasis endemic focus in Chiapas, Mexico was performed. Every individual under study was physically examined for signs of onchocerciasis in particular for subcutaneous nodules, dermic lesions, ocular damage and history of Mazzotti reaction. Of the total cases, 91.7% were positive for skin microfilariae. Only 32.2% of the microfilariae positive cases carried at least one palpable nodule. The sensitivity of the ELISA test was 92.3% for serum and 85.9% for urine. A good correlation between the transformed numbers of skin microfilariae (square root of x + 1) and the positivity of the ELISA test for serum and for urine was found. It was also observed that the ELISA test values for the sera and for the urine showed a good correlation with r = 0.76 and Z0.95 less than 0.005. This serological test can be used for seroepidemiological surveys and for orientating the activity of massive onchocerciasis treatment campaigns.
 ...
PMID:Antigen detection in onchocerciasis: correlation with worm burden. 274 Jul 27

Midazolam, a water soluble benzodiazepine derivative, inhibited the motility of Onchocerca volvulus microfilariae in vitro at concentrations of 25, 50, and 100 micrograms/ml. The effect was proportional to the concentrations used. Microfilariae regained motility after elimination of midazolam by washing. Diethylcarbamazine did not alter the midazolam effect. It is suggested that the Mazzotti reaction as the sequelae of diethylcarbamazine is caused by transient increased microfilarial migration. Combining midazolam with the diethylcarbamazine medication may prevent the Mazzotti reaction.
 ...
PMID:The paralyzing effect of midazolam on Onchocerca volvulus microfilariae in vitro. 360 96

Diethylcarbamazine (DEC) administered orally to jirds and striped mice (300 mg/kg for five days) was effective against the microfilariae of Monanema globulosa in experimental infections. Based on the small numbers of animals used in this trial, it is questionable whether the drug had significant activity against the adult worms in pulmonary arteries. Densities of microfilariae in the ears (mf/mg) fell by 80-100% of pretreatment levels over a four week period following treatment. There was no apparent action of the developing embryos in utero, and in some rodents densities of microfilariae in the skin returned to 73-88% of pretreatment levels within 70 days. No microfilariae were detected in the blood or urine during treatment. Twenty-four hours after the first dose of DEC, many of the microfilariae in the dermis became surrounded by a local infiltration of neutrophils, eosinophils and histiocytes. Cellular reactions were accompanied by an acute pruritus in rodents, as indicated by scratching and distress exhibited soon after treatment: No reactions to microfilariae were seen in untreated rodents. Similarities between this response and the Mazzotti reaction induced by DEC in human onchocerciasis indicate that M. globulosa may be of value as a rodent model to study adverse drug reactions in Onchocerca volvulus infections.
 ...
PMID:The action of diethylcarbamazine on the skin-dwelling microfilariae of Monanema globulosa (Nematoda: Filarioidea) in rodents. 671 Jun 1

Ivermectin is the drug of choice for the treatment of onchocerciasis. However at the recommended dose of 150 micrograms/kg, it neither kills nor permanently sterilises the adult worms. We investigated whether high doses given with and without a preceding 150 micrograms/kg 'clearing' dose would be tolerable as well as effective against the adult worms. Seventy-five healthy males with moderate to heavy infections with Onchocerca volvulus were enrolled in a double-blind trial to receive one of the following treatment regimens: 150 micrograms/kg followed by placebo (9 patients); 400 micrograms/kg with (9 patients) or without (16 patients) a clearing dose; 600 micrograms/kg with (8 patients) or without (16 patients) a clearing dose and 800 micrograms/kg with (8 patients) or without (9 patients) a clearing dose. Detailed examinations were conducted before and at various times after treatment. A preliminary report on the clinical and laboratory safety as at 30 days is presented. All the regimens were well tolerated. No clinical or laboratory drug related effects were observed. The overall severity of the Mazzotti reaction was similar in all groups. Ocular reactions were minimal and there were no changes in ocular function or in fluorescein angiograms. The groups were similar in the extent of microfilaricidal activity; there was however a suggestion that microfilariae were killed more rapidly at 400 micrograms/kg and 600 micrograms/kg but not at 800 micrograms/kg. This needs further study. Single doses of ivermectin up to 800 micrograms/kg are well tolerated; no special precautions for treatment monitoring are required and a 'clearing' dose is not necessary.
 ...
PMID:The chemotherapy of onchocerciasis. XIX: The clinical and laboratory tolerance of high dose ivermectin. 852 85